ALCHERA, Elisa
 Distribuzione geografica
Continente #
EU - Europa 433
NA - Nord America 378
AS - Asia 182
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 997
Nazione #
US - Stati Uniti d'America 376
IE - Irlanda 145
DE - Germania 86
SE - Svezia 70
CN - Cina 61
IT - Italia 45
UA - Ucraina 44
HK - Hong Kong 36
FI - Finlandia 27
SG - Singapore 27
TR - Turchia 22
IN - India 19
IR - Iran 13
CZ - Repubblica Ceca 4
FR - Francia 4
VN - Vietnam 4
CA - Canada 2
EU - Europa 2
GB - Regno Unito 2
AU - Australia 1
BE - Belgio 1
BY - Bielorussia 1
GR - Grecia 1
HU - Ungheria 1
LT - Lituania 1
PE - Perù 1
RU - Federazione Russa 1
Totale 997
Città #
Dublin 145
Jacksonville 86
Dearborn 53
Hong Kong 34
Chandler 32
Kocaeli 21
San Mateo 18
Beijing 17
Singapore 17
Wilmington 17
Lawrence 16
Princeton 16
Bremen 15
Piemonte 13
Andover 8
Hefei 8
Helsinki 8
Novara 8
Ann Arbor 6
Columbus 6
Ashburn 5
Augusta 5
Guangzhou 5
Kunming 5
Leawood 5
Munich 5
Zanjan 5
Ardabil 4
Brno 4
Dong Ket 4
Nanjing 4
Santa Clara 4
Milan 3
Monmouth Junction 3
Norwalk 3
Brescia 2
Hebei 2
Jinan 2
Ningbo 2
Sacramento 2
Toronto 2
Athens 1
Berlin 1
Brussels 1
Changsha 1
Düsseldorf 1
Hamilton 1
Hangzhou 1
Houston 1
Hyderabad 1
Jiaxing 1
Jinhua 1
Kish 1
Lima 1
London 1
Los Angeles 1
Minsk 1
Nanchang 1
Nanping 1
Quarto D'asti 1
Redmond 1
San Diego 1
Seattle 1
Shanghai 1
Shenyang 1
Stockholm 1
Taizhou 1
Vercelli 1
Wuxi 1
Zhengzhou 1
Zhoushan 1
Totale 650
Nome #
Lipid-induced ASK1 activation in hepatocytes and Kupffer cells mediates the increased vulnerability of fatty liver to ischemia/reperfusion injury in mice 86
Adenosine A2a receptor stimulation prevents hepatocyte lipotoxicity and nonalcoholic steatohepatitis (NASH) in rats. 77
The Balance between IL-17 and IL-22 produced by liver infiltrating T helper cells critically controls NASH development in mice 77
Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity 71
Pharmacological postconditioning protects against hepatic ischemia/reperfusion injury 70
Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype 69
Adenosine A2a receptor stimulation Reduces inflammatory Th cells subsets in steatotic mice liver and prevents progression to NASH 66
Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning 60
Mouse hepatocytes and LSEC proteome reveal novel mechanisms of ischemia/reperfusion damage and protection by A2aR stimulation 59
ROLE OF CARBONIC ANHYDRASE EXPRESSION IN HEPATOCYTE PROTECTION BY LATE PRECONDITIONING 57
Oxidative and ER stress-dependent ASK1 activation in steatotic hepatocytes and Kupffer cells sensitizes mice fatty liver to ischemia/reperfusion injury. 57
EFFECTS OF ADENOSINE A2A AND A1 RECEPTORS STIMULATION ON PALMITIC ACID AND HYPOXIA REOXYGENATION INJURY OF STEATOTIC MICE HEPATOCYTES 56
Role of p38 MAP kinase in glycine-induced hepatocyte resistance to hypoxic injury 54
IMMUNE REACTIONS IN STEATOHEPATITIS INITIATION AND PROGRESSION TO FIBROSIS: CRITICAL ROLE OF TH17 AND TH22 LYMPHOCYTES 53
DUSP12 acts as a novel endogenous protective signal against hepatic ischemia–reperfusion damage by inhibiting ASK1 pathway 51
Ischemia/reperfusion injury of fatty liver is protected by a2ar and exacerbated by a1r stimulation through opposite effects on ask1 activation 37
Boosting intracellular sodium selectively kills hepatocarcinoma cells and induces hepatocellular carcinoma tumor shrinkage in mice 20
Totale 1.020
Categoria #
all - tutte 5.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020166 0 0 0 0 0 40 54 10 17 29 14 2
2020/2021132 14 0 14 0 14 6 14 1 14 36 15 4
2021/2022120 2 14 11 11 11 1 8 3 9 1 27 22
2022/2023287 16 15 19 1 24 26 9 11 140 3 14 9
2023/2024123 13 7 5 4 22 4 15 1 1 13 25 13
2024/202553 14 2 18 1 17 1 0 0 0 0 0 0
Totale 1.020